文献速递眼底病与葡萄膜炎

HIV与非HIV患者巨细胞病毒性视网膜炎的视力预后与临床特征比较

COMPARISON OF VISUAL PROGNOSIS AND CLINICAL FEATURES OF CYTOMEGALOVIRUS RETINITIS IN HIV AND NON-HIV PATIENTS.
PubMed 文献 · Retina · 2017-01-01

该回顾性横断面研究纳入78眼(58例)巨细胞病毒性视网膜炎患者,比较HIV与非HIV患者的视力预后和临床特征。两组最佳矫正视力、黄斑受累率、视网膜脱离率、受累分区及死亡率均无显著差异。抗病毒治疗后视力整体显著变差,预后不良与1区受累、视网膜脱离及全身状况差显著相关。

要点

  • HIV与非HIV患者的巨细胞病毒性视网膜炎视力预后及临床特征无显著差异。
  • 抗病毒治疗后视力显著变差:治疗前logMAR 0.54±0.67(Snellen 20/63)vs 治疗后0.77±0.94(Snellen 20/125),P=0.014。
  • 预后不良与1区受累、视网膜脱离及全身状况差显著相关。

核心结论

  • HIV与非HIV患者的巨细胞病毒性视网膜炎总体视力预后和临床特征无差异。
  • 尽管抗病毒治疗不断进步,巨细胞病毒性视网膜炎的视力预后仍相当差。
  • 抗病毒治疗后预后不良与随访期间视网膜脱离、1区受累及患者全身状况差相关。

研究设计与样本

  • 回顾性横断面研究,纳入诊断为巨细胞病毒性视网膜炎的患者,按是否合并HIV感染分组分析最佳矫正视力与临床特征。
  • 共纳入78眼(58例),其中HIV患者21眼、非HIV患者57眼。

主要发现

  • HIV与非HIV患者的最佳矫正视力无显著差异。
  • 两组的黄斑受累率、视网膜脱离率、受累分区及死亡率均无显著差异。
  • 抗病毒治疗后视力显著变差:治疗前logMAR最佳矫正视力0.54±0.67(Snellen 20/63),治疗后0.77±0.94(Snellen 20/125),P=0.014。
  • 视力预后不良与1区受累、视网膜脱离及全身状况差显著相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare the visual prognosis and clinical features of cytomegalovirus (CMV) retinitis between HIV and non-HIV patients. METHODS: Retrospective cross-sectional study on patients diagnosed with CMV retinitis. Depending on the presence of HIV infection, best-corrected visual acuity (VA) and clinical feature of CMV retinitis were analyzed. The clinical characteristics associated with poor visual prognosis after antiviral treatment were also identified. RESULTS: A total of 78 eyes (58 patients) with CMV retinitis were included in this study: 21 eyes and 57 eyes in HIV and non-HIV patients, respectively. Best-corrected VA was not significantly different between HIV and non-HIV patients. The rate of foveal involvement, retinal detachment, involved zone, and mortality did not significantly differ between the two groups. Visual acuity after antiviral treatment was significantly worse (pretreatment logarithm of the minimal angle of resolution best-corrected VA, 0.54 ± 0.67 [Snellen VA, 20/63]; posttreatment logarithm of the minimal angle of resolution best-corrected VA, 0.77 ± 0.94 [Snellen VA, 20/125]; P = 0.014). Poor visual prognosis was significantly associated with Zone 1 involvement, retinal detachment, and a poor general condition. CONCLUSION: The overall visual prognosis and the clinical features of CMV retinitis do not differ between HIV and non-HIV patients. The visual prognosis of CMV retinitis still remains quite poor despite advancements in antiviral treatment. This poor prognosis after antiviral treatment is associated with retinal detachment during follow-up, Zone 1 involvement, and the poor general condition of the patient.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Kim DY, Jo J, Joe SG, et al. COMPARISON OF VISUAL PROGNOSIS AND CLINICAL FEATURES OF CYTOMEGALOVIRUS RETINITIS IN HIV AND NON-HIV PATIENTS. Retina. 2017. PMID: 28118285. doi:10.1097/IAE.0000000000001144

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。